152 related articles for article (PubMed ID: 36013602)
1. The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma.
Kunac N; Filipović N; Kostić S; Vukojević K
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013602
[No Abstract] [Full Text] [Related]
2. Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression.
Lomperta K; Jakubowska K; Grudzinska M; Kanczuga-Koda L; Wincewicz A; Surmacz E; Sulkowski S; Koda M
World J Gastroenterol; 2020 Jul; 26(28):4140-4150. PubMed ID: 32821075
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.
De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP
Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519
[TBL] [Abstract][Full Text] [Related]
5. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer.
Kanczuga-Koda L; Sulkowski S; Koda M; Skrzydlewska E; Sulkowska M
World J Gastroenterol; 2005 Mar; 11(10):1544-8. PubMed ID: 15770735
[TBL] [Abstract][Full Text] [Related]
6. Is Bax/Bcl-2 ratio considered as a prognostic marker with age and tumor location in colorectal cancer?
Khodapasand E; Jafarzadeh N; Farrokhi F; Kamalidehghan B; Houshmand M
Iran Biomed J; 2015; 19(2):69-75. PubMed ID: 25864810
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and differential expression of apoptosis-related proteins in endometriotic glandular and stromal cells.
Goumenou AG; Matalliotakis IM; Tzardi M; Fragouli YG; Mahutte NG; Arici A
J Soc Gynecol Investig; 2004 Jul; 11(5):318-22. PubMed ID: 15219886
[TBL] [Abstract][Full Text] [Related]
8. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
9. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
10. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt.
Zalata KR; Nasif WA; Ming SC; Lotfy M; Nada NA; El-Hak NG; Leech SH
Cell Oncol; 2005; 27(4):245-53. PubMed ID: 16308474
[TBL] [Abstract][Full Text] [Related]
11. [Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis].
Li L; Yan L; Liu Z; Wang Z; Wen T; Chen X; Huang G
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):614-6, 120. PubMed ID: 11825479
[TBL] [Abstract][Full Text] [Related]
12. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-2 and Bax in extrahepatic biliary tract carcinoma and dysplasia.
Li SM; Yao SK; Yamamura N; Nakamura T
World J Gastroenterol; 2003 Nov; 9(11):2579-82. PubMed ID: 14606101
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinicopathological significance of
Yang XG; Yang JW; Zhao PJ; Cheng W; Shi HB; Zhang B; Fu QC; Li Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):148-153. PubMed ID: 34008361
[TBL] [Abstract][Full Text] [Related]
15. Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.
Ma M; Wang X; Liu N; Shan F; Feng Y
Int Immunopharmacol; 2020 Jun; 83():106388. PubMed ID: 32171145
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
17. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.
Itoh J; de La Motte C; Strong SA; Levine AD; Fiocchi C
Gut; 2001 Jul; 49(1):35-41. PubMed ID: 11413108
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
[TBL] [Abstract][Full Text] [Related]
19. Bax and Bcl-2 are focally overexpressed in the normal epithelium of cancerous prostates.
Tolonen TT; Tommola S; Jokinen S; Parviainen T; Martikainen PM
Scand J Urol Nephrol; 2007; 41(2):85-90. PubMed ID: 17454944
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
